Having trouble accessing articles? Reset your cache.

Genzyme misses Street

Genzyme Corp. (NASDAQ:GENZ) reported 3Q10 non-GAAP EPS of $0.42, missing the Street's estimate of $0.53 but up from $0.28 in 3Q09. Revenues for the quarter were $1 billion,

Read the full 288 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE